Genome sequencing reveals driving mutations behind common brain tumor

The following is an excerpt.

Large-scale genomic sequencing has identified two DNA mutations that appear to drive about 15 percent of brain tumours known as meningiomas, a finding that could lead to the first effective drug treatments for the tumours, report scientists from Dana-Farber Cancer Institute and the Broad Institute.

View the original article here: Genomic Sequencing Reveals Mutant ‘Drivers’ of Common Brain Tumour

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.